These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9696032)

  • 41. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
    Wang Q; Beck WT
    Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
    Moberg KH; Tyndall WA; Hall DJ
    J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of N-ras induced by ultraviolet irradiation in vitro.
    Van der Lubbe JL; Rosdorff HJ; Bos JL; Van der Eb AJ
    Oncogene Res; 1988; 3(1):9-20. PubMed ID: 3060800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation.
    Uchiumi T; Kohno K; Tanimura H; Matsuo K; Sato S; Uchida Y; Kuwano M
    Cell Growth Differ; 1993 Mar; 4(3):147-57. PubMed ID: 8466853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A potential transcriptional activation element in the p53 protein.
    O'Rourke RW; Miller CW; Kato GJ; Simon KJ; Chen DL; Dang CV; Koeffler HP
    Oncogene; 1990 Dec; 5(12):1829-32. PubMed ID: 2284102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiation-dependent p53 regulation of nucleotide excision repair in keratinocytes.
    Li G; Ho VC; Mitchell DL; Trotter MJ; Tron VA
    Am J Pathol; 1997 Apr; 150(4):1457-64. PubMed ID: 9095000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
    Albor A; Flessate DM; Soussi T; Notario V
    Cancer Res; 1994 Aug; 54(16):4502-7. PubMed ID: 8044802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage.
    Luethy JD; Holbrook NJ
    Cancer Res; 1992 Jan; 52(1):5-10. PubMed ID: 1727386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of ES cell differentiation by functional and conformational modulation of p53.
    Sabapathy K; Klemm M; Jaenisch R; Wagner EF
    EMBO J; 1997 Oct; 16(20):6217-29. PubMed ID: 9321401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Gene product p53 is involved in the regulation of activity of the c-fos proto-oncogene promotor].
    Vikhanskaia FL; Pospelova TV; Volkov IV; Kukushkin AN; Svetlikova SB; Poslepov VA
    Dokl Akad Nauk SSSR; 1991; 321(4):846-9. PubMed ID: 1806357
    [No Abstract]   [Full Text] [Related]  

  • 52. Definition of a DNA repair domain in the genomic region containing the human p53 gene.
    Tolbert DM; Kantor GJ
    Cancer Res; 1996 Jul; 56(14):3324-30. PubMed ID: 8764129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Protein p53 inhibits the activity of the enhancer of the immediate-early genes of murine cytomegalovirus].
    Lembo D; Angeretti A; Cavallo R; Gariglio M; Gribaudo G; Landolfo S
    G Batteriol Virol Immunol; 1994; 86(1-12):43-54. PubMed ID: 8706975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-type- and promoter-dependent ts phenotype of p53 Val135.
    Sehgal PB; Margulies L
    Oncogene; 1993 Dec; 8(12):3417-9. PubMed ID: 8247545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats.
    Haas MJ; Pitot HC
    Mol Carcinog; 1998 Feb; 21(2):128-34. PubMed ID: 9496913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent.
    Forrester K; Lupold SE; Ott VL; Chay CH; Band V; Wang XW; Harris CC
    Oncogene; 1995 Jun; 10(11):2103-11. PubMed ID: 7784055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strand-specific removal of cyclobutane pyrimidine dimers from the p53 gene in the epidermis of UVB-irradiated hairless mice.
    Ruven HJ; Seelen CM; Lohman PH; van Kranen H; van Zeeland AA; Mullenders LH
    Oncogene; 1994 Dec; 9(12):3427-32. PubMed ID: 7970701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptional repression of fibronectin gene expression in v-src transformation.
    Gu H; Oliver N
    Exp Cell Res; 1995 Apr; 217(2):428-39. PubMed ID: 7698243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel DNA binding of p53 mutants and their role in transcriptional activation.
    Zhang W; Funk WD; Wright WE; Shay JW; Deisseroth AB
    Oncogene; 1993 Sep; 8(9):2555-9. PubMed ID: 8361764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage.
    Magrini R; Russo D; Fronza G; Inga A; Menichini P
    J Cell Biochem; 2007 Apr; 100(5):1276-87. PubMed ID: 17063487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.